Free Trial

DENTSPLY SIRONA Q2 EPS Forecast Lifted by Leerink Partnrs

DENTSPLY SIRONA logo with Medical background

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Analysts at Leerink Partnrs boosted their Q2 2025 EPS estimates for shares of DENTSPLY SIRONA in a research report issued on Monday, July 14th. Leerink Partnrs analyst M. Cherny now forecasts that the medical instruments supplier will earn $0.49 per share for the quarter, up from their prior estimate of $0.46. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA's Q3 2025 earnings at $0.46 EPS, FY2025 earnings at $1.90 EPS, FY2026 earnings at $2.06 EPS and FY2027 earnings at $2.32 EPS.

Other equities analysts have also issued research reports about the stock. Piper Sandler decreased their price target on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a report on Wednesday, April 30th. Barrington Research increased their target price on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an "outperform" rating in a report on Monday, May 12th. UBS Group reduced their target price on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Morgan Stanley lowered shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a report on Tuesday, April 15th. Finally, Wall Street Zen raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Sunday. Eleven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $20.36.

View Our Latest Stock Report on DENTSPLY SIRONA

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY traded up $0.01 during trading on Wednesday, reaching $15.82. The company had a trading volume of 1,467,576 shares, compared to its average volume of 2,909,907. The company has a fifty day moving average of $16.08 and a two-hundred day moving average of $16.34. The stock has a market capitalization of $3.15 billion, a P/E ratio of -3.48, a price-to-earnings-growth ratio of 1.14 and a beta of 0.94. DENTSPLY SIRONA has a 12 month low of $12.16 and a 12 month high of $27.95. The company has a current ratio of 1.10, a quick ratio of 0.76 and a debt-to-equity ratio of 0.79.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. The firm had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The business's revenue for the quarter was down 7.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.42 EPS.

Institutional Investors Weigh In On DENTSPLY SIRONA

Institutional investors have recently added to or reduced their stakes in the company. Colonial Trust Co SC purchased a new stake in DENTSPLY SIRONA during the 4th quarter valued at $26,000. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth about $25,000. Brooklyn Investment Group purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth about $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth about $26,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of DENTSPLY SIRONA by 700.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after purchasing an additional 1,568 shares during the period. Hedge funds and other institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, July 11th. Shareholders of record on Friday, June 27th were given a dividend of $0.16 per share. The ex-dividend date was Friday, June 27th. This represents a $0.64 annualized dividend and a yield of 4.05%. DENTSPLY SIRONA's payout ratio is currently -14.10%.

DENTSPLY SIRONA Company Profile

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines